Efficacy and Safety of ASP7147, a Bombesin-2 Receptor Antagonist, in Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D): Results of a Multicenter, Double-Blind, Placebo-Controlled Trial

Category Primary study
JournalGastroenterology
Year 2015
This article has no abstract
Epistemonikos ID: 51f54817ffa7f48c0c5bdaa6f6982311244e4787
First added on: Feb 07, 2025